ClinicalTrials.govpublic full text
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease
chronic kidney disease, ojr520, safety and tolerability, pk, pd, healthy volunteers, first in human, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 913425
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.